Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Molly McElwee-Malloy"'
Autor:
Jordan E. Pinsker, Steph Habif, Harsimran Singh, Krista Kriegel, Scott Leas, Molly McElwee Malloy, Alexandra Constantin
Publikováno v:
Diabetes Technology & Therapeutics
Insulin pump training has traditionally been performed in-person. The coronavirus disease 2019 (COVID-19) pandemic necessitated vast increases in the number of virtual pump trainings for Tandem t:slim X2 insulin pump starts. A customized structured p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304341847d36b969e84cfe4c8b708e8e
https://doi.org/10.1089/dia.2020.0602
https://doi.org/10.1089/dia.2020.0602
Autor:
Molly McElwee-Malloy, Betsy B Dokken, Kirstin N. White, Lars Mueller, Alexandra Constantin, Stephanie Habif, Harsimran Singh, Jordan E. Pinsker
Publikováno v:
Diabetes. 70
The Control-IQ technology Observational (CLIO) study prospectively follows a large, diverse cohort with type 1 diabetes with varied insulin use and baseline glycemic control. To study insulin use on the t:slim X2 pump with Control-IQ technology, we c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a66a6ca21987d5dc3412c8ca99360b7
https://doi.org/10.2337/db21-92-lb
https://doi.org/10.2337/db21-92-lb
Publikováno v:
Diabetes. 70
The Tandem Diabetes Care® t:slim X2TM insulin pump with Control-IQTM technology is an advanced hybrid closed-loop system, cleared by the FDA in December 2019. To date various studies have demonstrated glycemic and patient-reported improvements using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16b9a0728f0b7b0afdef3fbe22fb0831
https://doi.org/10.2337/db21-531-p
https://doi.org/10.2337/db21-531-p
Autor:
Harsimran Singh, Jordan E. Pinsker, Alexandra Constantin, Molly McElwee Malloy, Lars Müller, Michelle L. Manning, Steph Habif, Scott Leas
Publikováno v:
Diabetes Technology & Therapeutics
Background: The t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid closed-loop system, became available in the United States in early 2020. Real-world outcomes with use of this system have not yet been comprehensively reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd1ed23002c75a4f06c80aae7ed04a4
https://pubmed.ncbi.nlm.nih.gov/32846114
https://pubmed.ncbi.nlm.nih.gov/32846114
Publikováno v:
Diabetes. 69
Severe hypoglycemia (SH) is an acute complication of diabetes with potentially adverse clinical and psychosocial consequences. There is little published literature in terms of SH-related adverse events (AEs) in patients with type 1 diabetes (PwT1D) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e76fec911d949c6aa9d77559ca08e57
https://doi.org/10.2337/db20-267-or
https://doi.org/10.2337/db20-267-or
Publikováno v:
Journal of the Endocrine Society
Recent literature has highlighted remarkable clinical benefits of the Basal-IQ PredictiveLow Glucose Suspend (PLGS) technology for both pediatric and adult patients with type 1diabetes (PwT1D). Although less frequently acknowledged in the literature,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0ee733696a3ce2d6e521818fa64ed5
https://doi.org/10.1210/jendso/bvaa046.2088
https://doi.org/10.1210/jendso/bvaa046.2088
Autor:
Alicia H. McAuliffe-Fogarty, Dana Ball, Gina Agiostratidou, Stuart A. Weinzimer, Evgenia Gourgari, Kent Reifschneider, Paul Madden, Henry Anhalt, Aaron J. Kowalski, Anne Peters, Karen N. Harriman, Molly McElwee-Malloy, Karen Rubin, Sripriya Raman, Lawrence Blonde
Publikováno v:
Diabetes Care
OBJECTIVE To identify and define clinically meaningful type 1 diabetes outcomes beyond hemoglobin A1c (HbA1c) based upon a review of the evidence, consensus from clinical experts, and input from researchers, people with type 1 diabetes, and industry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::849ba8736add231ce146ea0372d61922
https://doi.org/10.2337/dc17-1624
https://doi.org/10.2337/dc17-1624
Publikováno v:
Diabetes. 68
Background: Understanding qualities that make up trust in AID systems is imperative for successful development of systems built for long-term use. Previous research has demonstrated that trust is associated with: (a) better glycemic outcomes, (b) dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc12c31109353cef0726abffbea04a55
https://doi.org/10.2337/db19-84-lb
https://doi.org/10.2337/db19-84-lb
Publikováno v:
Journal of the Endocrine Society
The COVID-19 pandemic led to a digital evolution in the healthcare industry by necessitating widespread adoption of telehealth and other remote services to enable engagement with patients. Diabetes management is well suited for telehealth utilization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c64d112bb1e9f690a8acd8c6a1fa277e
http://europepmc.org/articles/PMC8089640
http://europepmc.org/articles/PMC8089640
Publikováno v:
Journal of Diabetes Science and Technology. 9:1192-1199
Background: Factors influencing glycemic variability in type 1 diabetes (T1D) may play a significant role in the refinement of closed loop insulin administration. Phase of menstrual cycle is one such factor that has been inadequately investigated. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeae9a605f35a82922c18277a18c2bc0
https://doi.org/10.1177/1932296815608400
https://doi.org/10.1177/1932296815608400